HERON THERAPEUTICS, INC. /DE/·4

Jan 20, 2:49 PM ET

Duarte Ira 4

4 · HERON THERAPEUTICS, INC. /DE/ · Filed Jan 20, 2026

Insider Transaction Report

Form 4
Period: 2026-01-19
Duarte Ira
EVP, Chief Financial Officer
Transactions
  • Exercise/Conversion

    Common Stock

    [F1]
    2026-01-19+3,875183,661 total
  • Exercise/Conversion

    Restricted Stock Units

    [F2]
    2026-01-193,87530,994 total
    Exercise: $0.00Common Stock (3,875 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of common stock.
  • [F2]The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024).
Signature
/s/Kathryn Lester Attorney-in-fact for Ira Duarte|2026-01-20

Documents

1 file
  • 4
    ownership.xmlPrimary

    4